Business
Notification of Full Year Results
Notification of Full Year Results.
About this update from Immupharma Plc
[{"type":"text","content":"\n \nRNS Number : 7012F Immupharma PLC 22 May 2017 \n\n \n 22 MAY 2017\n \n \n \nImmuPharma PLC\n(\"ImmuPharma\" or the \"Company\")\n \nNOTIFICATION OF FULL YEAR RESULTS\nDate: 1 June 2017\nImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, confirms that it will be announcing its full year results for the year ended 31 December 2016 on Thursday 1 June 2017.\n \n \n-Ends-\n \n \n \n\n\n\n\nFor further information please contact:\n \n\n\n\n\nImmuPharma plc (www.immupharma.org)\n\n\n+ 44 (0) 20 7152 4080\n\n\n\n\nTim McCarthy, Chairman\n\n\n\n\n\n\n\nLisa Baderoon, Head of Investor Relations\nTwitter: @immupharma\n \n\n\n+ 44 (0) 7721 413496\n \n \n\n\n\n\n\n\n\n\n\n\n\n\n \nNorthland Capital Partners Limited (Joint Broker)\nPatrick Claridge, David Hignell, Corporate Finance\nRob Rees, Corporate Broking\n \n \n\n\n \n+44 (0)20 3861 6625\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange END NORKMGMKZLVGNZM\n ","length":4763,"tagName":"div"}]